ARUP LABORATORIES, INC.

Budget/Appropriations

Monitor the following: Public Law 119-75, Consolidated Appropriations Act, 2026, Division B - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Diagnostic Lab Testing related issues President's Budget FY2027

Health Issues

FDA regulation, Laboratory Testing related issues H.R.8890, Clinical Laboratory Improvement Amendments (CLIA), Modernization generally H.R.5269/S.2761, Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 (RESULTS Act), Entirety Monitor the following: Possible Health policy package Health workforce visa related issues H.R.3152/S.1546, Patent Eligibility Restoration Act of 2025, Laboratory technology related issues Possible Reconciliation, FY2026 and FY2027, Health related provisions Prescription drug costs, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Public Health reporting initiatives

TargetedHOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs

FDA regulation, Laboratory Testing related issues H.R.8890, Clinical Laboratory Improvement Amendments (CLIA), Modernization generally H.R.5269/S.2761, Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 (RESULTS Act), Entirety Monitor the following: Possible Health policy package Health workforce visa related issues H.R.3152/S.1546, Patent Eligibility Restoration Act of 2025, Laboratory technology related issues Possible Reconciliation, FY2026 and FY2027, Health related provisions Prescription drug costs, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Public Health reporting initiatives